2 December 2025

New International research group created to advance the use of biomaterials for bone regeneration and bone cancer

Biomedical Technologies for Regenerative Orthopaedics (BioTROCS) is a new joint research group that brings together the Royal Orthopaedic Hospital, Aston...

Read More
12 August 2025

Clinical Trial underway: Do we need radiotherapy following surgery for pathological fractures on metastatic bone cancer patients?

Approximately 70% of people with advanced breast and prostate cancer develop secondary bone cancer (metastases). This disease weakens the bone,...

Read More
20 February 2025

Aston University collaboration to develop injectable paste which could treat bone cancer

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal Orthopaedic Hospital...

Read More
16 January 2025

Researchers at the Royal Orthopaedic Hospital secure funding to develop cancer-killing injectable paste for bone tumours

The Dubrowsky Lab at the Royal Orthopaedic Hospital (ROH) has secured a £110k grant from Orthopaedic Research UK to develop...

Read More
12 September 2024

Aston University develops novel bone cancer therapy which has 99% success rate

Bioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined...

Read More
4 July 2024

Researchers at the Royal Orthopaedic Hospital explore novel bone cancer therapy

Lucas Souza, Research Laboratory Manager for the Dubrowsky Regenerative Medicine Laboratory at the Royal Orthopaedic Hospital, is partnered with Prof...

Read More
4 October 2022

Europe committed to bringing to market an innovative treatment for bone cancer

The European Research Council has awarded professor Cristina Canal a Proof of Concept grant, which aims to bridge the gap...

Read More
5 October 2020

Researchers use soy to improve bone cancer treatment

Researchers in recent years have demonstrated the health benefits of soy, linking its consumption to reduced risk of cardiovascular disease,...

Read More
TRENDING NEWS

New genetic insights into developmental dysplasia of the hip

- 30 April 2026

New white paper explores the injection set to redefine the treatment of knee osteoarthritis

- 23 April 2026

Using menstrual blood-derived particles to treat osteoarthritis?

- 21 April 2026

Could a UK-born device evaluation model become a global benchmark?

- 16 April 2026

50 Year Charnley Hip Replacement still going strong

- 14 April 2026

New global study using data from the National Joint Registry, estimates that modern hip replacements could last at least 30 years

- 9 April 2026
BROWSE BY SECTION